ICU Medical (ICUI) Tops Q2 EPS by 10c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
ICU Medical, Inc. Announces Second Quarter 2016 Results
August 8, 2016 4:05 PM EDTSAN CLEMENTE, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the second quarter ended June 30, 2016.
Second Quarter 2016 Results
Second quarter 2016 revenue was $96.7 million, compared to $83.8 million in the same period last year. GAAP net income for the second quarter of 2016 was $16.6 million, or $0.98 per diluted share, as compared to GAAP net income of $13.6 million, or $0.83 per diluted share, for the second quarter of... More



